The Medical Biology Institute under the Academy of Medical Science in the DPRK succeeded in developing a recombinant subunit vaccine for COVID-19. The vaccine is designed on the basis of gene sequence of virus spike protein which binds Angiotensin-Converting Enzyme 2 (ACE2), the receptor for SARS-CoV-2. The safety and immunogenicity of the vaccine was verified […]
